Admission to Trading

AI SummaryClose X

Oxford Biomedica has admitted 430,825 new ordinary shares of 50p (ISIN GB00BDFBVT43) to trading on the LSE Main Market following allotments under its Long Term Incentive Plan and Deferred Bonus Plan, taking total issued shares to 121,480,983 and representing approximately a 0.36% increase in issued share capital; the new shares are confirmed fungible with existing shares and the notification covers 5 October–12 November 2026.

Disclaimer*

UK 100

Latest directors dealings